Oral Delivery of a Tetrameric Tripeptide Inhibitor of VEGFR1 Suppresses Pathological Choroid Neovascularization

Efficacy of Lenvatinib, a multitargeted tyrosine kinase inhibitor, on laser-induced CNV mouse model of neovascular AMD

(2018) Xian Wei et al.   EXPERIMENTAL EYE RESEARCH

Automatic procedures for the synthesis of difficult peptides using oxyma as activating reagent: A comparative study on the use of bases and on different deprotection and agitation conditions

(2018) A. Caporale et al.   PEPTIDES

Full Functional Knockout of Placental Growth Factor by Knockin with an Inactive Variant Able to Heterodimerize with VEGF-A

(2018) Ivana Apicella et al.   Cell Reports

A Revised Hemodynamic Theory of Age-Related Macular Degeneration

(2016) Bradley D. Gelfand et al.   TRENDS IN MOLECULAR MEDICINE

The vascular endothelial growth factors and receptors family: Up to now the only target for anti-angiogenesis therapy

(2015) Valeria Tarallo et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Discovery of Oral VEGFR-2 Inhibitors with Prolonged Ocular Retention That Are Efficacious in Models of Wet Age-Related Macular Degeneration

(2015) Erik L. Meredith et al.   JOURNAL OF MEDICINAL CHEMISTRY

Powerful anti-tumor and anti-angiogenic activity of a new anti-vascular endothelial growth factor receptor 1 peptide in colorectal cancer models

(2015) Valeria Cicatiello et al.   Oncotarget

Antiangiogenesis therapy: an update after the first decade

(2014) Sandro De Falco   KOREAN JOURNAL OF INTERNAL MEDICINE

Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis

(2014) Wan Ling Wong et al.   Lancet Global Health

Non-responders to treatment with antagonists of vascular endothelial growth factor in age-related macular degeneration

(2013) Ilse Krebs et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature

(2013) K Ghasemi Falavarjani et al.   EYE

Seven-Year Outcomes in Ranibizumab-Treated Patients in ANCHOR, MARINA, and HORIZON

(2013) Soraya Rofagha et al.   OPHTHALMOLOGY

Risk of Geographic Atrophy in the Comparison of Age-related Macular Degeneration Treatments Trials

(2013) Juan E. Grunwald et al.   OPHTHALMOLOGY

Intravitreal Aflibercept Injection for Neovascular Age-related Macular Degeneration

(2013) Ursula Schmidt-Erfurth et al.   OPHTHALMOLOGY

PlGF: A Multitasking Cytokine with Disease-Restricted Activity

(2013) M. Dewerchin et al.   Cold Spring Harbor Perspectives in Medicine

Signal Transduction by Vascular Endothelial Growth Factor Receptors

(2013) S. Koch et al.   Cold Spring Harbor Perspectives in Medicine

Initial Exploration of Oral Pazopanib in Healthy Participants and Patients With Age-Related Macular Degeneration

(2013) Megan M. McLaughlin et al.   JAMA Ophthalmology

Targeted deletion of Vegfa in adult mice induces vision loss

(2012) Toshihide Kurihara et al.   JOURNAL OF CLINICAL INVESTIGATION

Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration

(2011)   NEW ENGLAND JOURNAL OF MEDICINE

Infrared study of trifluoroacetic acid unpurified synthetic peptides in aqueous solution: Trifluoroacetic acid removal and band assignment

(2010) Laura E. Valenti et al.   ANALYTICAL BIOCHEMISTRY

Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting

(2010) Lars Jakobsson et al.   NATURE CELL BIOLOGY

Modulation of Angiogenesis by a Tetrameric Tripeptide That Antagonizes Vascular Endothelial Growth Factor Receptor 1

(2008) Salvatore Ponticelli et al.   JOURNAL OF BIOLOGICAL CHEMISTRY